Stanford Biotechnology Group

Stanford Biotech Group Podcast

The Stanford Biotech Group Podcast is your front-row seat to the people shaping the future of the life sciences. Run by Stanford graduate and professional students across PhD, MD, MBA, and MS programs, we sit down with the scientists, founders, and investors driving biotech forward. Let's pulling back the curtain on the breakthroughs, bets, and big ideas redefining medicine!

Autor

Stanford Biotechnology Group

Categorie

Science

Cel mai nou episod

17 nov. 2026

Unde asculți?

Podcasturi în aplicație Replaio Radio În curând

Podcasturile ajung în curând în aplicație. Instaleaz-o acum și fii primul care descoperă o abordare complet nouă a podcasturilor

Descarcă din Google Play Instalează gratuit Android 10 mil.+ descărcări · nota 4,7+ iOS în curând

Episoade

Who Owns the Discovery? Biotech Patents and AI with Julia Minitti 17.11.2026

What should you think about before sharing a discovery in a preprint, on a conference poster, or with a chatbot? Host Afi Tagnedji sits down with Julia Minitti, a Wilson Sonsini patent partner and former medicinal chemist, to talk about when to file a patent, what investors look for in a biotech startup’s intellectual property, and who gets credit when AI helps design a drug. Julia also shares wha...

The Future of Farming Is Biotech 02.11.2026

In this episode of the Stanford Biotech Group Podcast, our Co-VP of Communications, Mikaela Ribi, sits down with Tim Schnabel, founder and CEO of Switch Bioworks, a Stanford spinout engineering microbes to produce sustainable nitrogen fertilizer. Together, we explore his journey from PhD research to entrepreneurship, the challenges of translating scientific discoveries into practical solutions, an...

World-Class Science. But Where Are Australia’s Biotechs? 21.10.2026

Our guest is Dr. Bob Soh, a partner at Brandon Capital, Australia’s biggest life sciences venture capital firm. Bob talks with Rui Yip about why Australia’s strong research base hasn’t produced a bigger biotech industry, and why overseas biotechs often run their Phase 1 trials here. They also cover how veterans of big pharma are helping launch new companies, how the local pool of biotech venture c...

Inside TwoStep: From the Bench to the Term Sheet, and Now, the Clinic 13.05.2026

Caitlyn Miller, CEO and co-founder of TwoStep Therapeutics, joins the SBG podcast to discuss her Series A biotech's five-target peptide platform for solid tumors, the path from Stanford PhD to funded company, and what no one tells you about founding.

Ascultă podcastul Stanford Biotech Group Podcast în Replaio

Radio și podcasturi într-o singură aplicație - gratuit și fără înregistrare. Instaleaz-o azi și nu rata lansarea

Descarcă din Google Play

Replaio nu este editorul podcasturilor; numele emisiunilor, coperțile și materialul audio aparțin autorilor lor și sunt distribuite prin fluxuri RSS publice